Crossmark

Recurrent skin reaction at the site of former subcutaneous injection after switching back to intravenous vedolizumab

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2023.06.006

Published Print: 2024-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cañete, Fiorella

Gonzalez-Gonzalez, Laura

Domènech, Eugeni http://orcid.org/0000-0002-2315-7196
Funding

Funding for this research was provided by:

Dr. Falk Pharma
License Information

Text and Data Mining valid from 2024-04-01

Text and Data Mining valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01
More Information

This article is maintained by: Elsevier

Article Title: Recurrent skin reaction at the site of former subcutaneous injection after switching back to intravenous vedolizumab

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2023.06.006

Content Type: simple-article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.